Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas

Detalhes bibliográficos
Autor(a) principal: Araldi, Isabel Cristina da Costa
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional Manancial UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/18149
Resumo: Malignant neoplasias constitute a public health issue, with around 600 thousand new cases of cancer projected to be diagnosed in Brazil between 2016 and 2017. In this context, breast cancer is the most common type in women, reaching around 28% of Brazilian women. Radiation therapy is a therapeutic modality commonly applied in cases of breast cancer in different stages. However, radioresistance, cutaneous radiation syndrome and the occurrence of new neoplasias in healthy cells are the main side effects of this practice. Therefore, the aim of this work was to assess the potential of resveratrol (RV) as a radiosensitizer radiomodifier on breast cancer cells of the lineage MCF-7. For this end, cells were initially treated with different RV doses (0, 10, 30 and 100μM) for 24 hours and then exposed to ionizing radiation (IR) (0, 1, 2 e 3 grays). The results show that the most cytotoxic treatment combination was 10μM and 3 grays, which were the doses chosen for the additional tests. Cellular death assessment through flow cytometry showed that, in 24 hours cell cultures after IR, necrosis/senescence seem to be related to cytotoxicity, besides the activation of extrinsic apoptosis. This phenomenon was clear when the high activity of caspases 3 and 8, and the low bax/bcl-2 ratio were observed. Tests involving oxidative metabolism show that RV and IR are effective together, causing great oxidative damage in DNA, proteins and cellular lipids, as well as diminishing the activity of the antioxidative enzymes dismutase (SOD) and catalase (CAT). The high expression of p53 indicates not to be primarily related to intrinsic apoptosis, but to be indeed related to the interruption of cell cycle in the S phase, which was observed in 72 hours cellular cultures after IR. Thus, the pro-oxidative condition established by the treatment combination, together with the high level of the p53 expression, allow us to suggest that the significant decrease of cellular proliferation in 72 hours cultures seems to be related to the irreversible growth interruption linked to necrosis/senescence, as well as apoptosis activation.
id UFSM-20_372a504d6066cd1f2a9dd8de42fc3ee3
oai_identifier_str oai:repositorio.ufsm.br:1/18149
network_acronym_str UFSM-20
network_name_str Repositório Institucional Manancial UFSM
repository_id_str 3913
spelling 2019-09-05T18:12:12Z2019-09-05T18:12:12Z2016-11-28http://repositorio.ufsm.br/handle/1/18149Malignant neoplasias constitute a public health issue, with around 600 thousand new cases of cancer projected to be diagnosed in Brazil between 2016 and 2017. In this context, breast cancer is the most common type in women, reaching around 28% of Brazilian women. Radiation therapy is a therapeutic modality commonly applied in cases of breast cancer in different stages. However, radioresistance, cutaneous radiation syndrome and the occurrence of new neoplasias in healthy cells are the main side effects of this practice. Therefore, the aim of this work was to assess the potential of resveratrol (RV) as a radiosensitizer radiomodifier on breast cancer cells of the lineage MCF-7. For this end, cells were initially treated with different RV doses (0, 10, 30 and 100μM) for 24 hours and then exposed to ionizing radiation (IR) (0, 1, 2 e 3 grays). The results show that the most cytotoxic treatment combination was 10μM and 3 grays, which were the doses chosen for the additional tests. Cellular death assessment through flow cytometry showed that, in 24 hours cell cultures after IR, necrosis/senescence seem to be related to cytotoxicity, besides the activation of extrinsic apoptosis. This phenomenon was clear when the high activity of caspases 3 and 8, and the low bax/bcl-2 ratio were observed. Tests involving oxidative metabolism show that RV and IR are effective together, causing great oxidative damage in DNA, proteins and cellular lipids, as well as diminishing the activity of the antioxidative enzymes dismutase (SOD) and catalase (CAT). The high expression of p53 indicates not to be primarily related to intrinsic apoptosis, but to be indeed related to the interruption of cell cycle in the S phase, which was observed in 72 hours cellular cultures after IR. Thus, the pro-oxidative condition established by the treatment combination, together with the high level of the p53 expression, allow us to suggest that the significant decrease of cellular proliferation in 72 hours cultures seems to be related to the irreversible growth interruption linked to necrosis/senescence, as well as apoptosis activation.As neoplasias malignas constituem um problema de saúde pública, sendo que, cerca de 600 mil novos casos de câncer estão previstos para o Brasil no biênio 2016-2017. Neste contexto, o câncer de mama (CM) é o mais incidente em mulheres, atingindo cerca de 28% das brasileiras. A radioterapia constitui em uma modalidade terapêutica amplamente empregada no tratamento de CM em diversos estágios. Porém, radiorresistência, síndrome cutânea da radiação, incidência de novas neoplasias em células saudáveis irradiadas compõem os principais efeitos colaterais dessa prática. Dessa forma, este trabalho buscou investigar o potencial do resveratrol (RV) como radiomodificador do tipo radiossensibilizador em células de CM da linhagem MCF-7. Para isso, as células foram tratadas inicialmente com diferentes doses de RV (0, 10, 30 e 100μM) por 24 horas e então foram expostas à radiação ionizante (RI) (0, 1, 2 e 3 grays). Os resultados mostraram que a combinação de tratamentos mais citotóxica foi 10 μM e 3 grays, sendo essas doses escolhidas para os testes complementares. A análise de morte celular através de citometria de fluxo mostrou que em culturas de 24 horas após a RI a necrose/senescência parece estar relacionada à citoxicidade, além da ativação da via extrínseca da apoptose, fenômeno que ficou claro ao observar a alta atividade das caspases 3 e 8 e baixa na relação bax/bcl-2. Testes envolvendo o metabolismo oxidativo mostraram que RV+RI são eficazes juntos, no sentido de proporcionar alto dano oxidativo ao DNA, proteínas e lipídios celulares, bem como diminuir a atividade das enzimas antioxidantes superóxido dismutase (SOD) e catalase (CAT). A alta expressão de p53, não está envolvida primeiramente na apoptose intrínseca, mas sim no bloqueio da fase S do ciclo celular, que foi observado em culturas de células 72 horas após a RI. Assim, a condição pro-oxidante estabelecida pela combinação dos tratamentos, junto ao alto nível de expressão de p53 permite sugerir que a diminuição expressiva da proliferação celular em culturas de 72 horas parece estar relacionada a parada irreversível de crescimento ligada a necrose/senescência, bem como a ativação da apoptose.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESporUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em FarmacologiaUFSMBrasilFarmacologiaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessRadiação ionizanteResveratrolRadioterapiaNeoplasiasRadiossensibilizaçãoIonizing radiationResveratrolRadiotherapyRadiosensitizationCNPQ::CIENCIAS DA SAUDE::FARMACIAAvaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadasEvaluation of resveratrol radiomodifier effect on irradiated breast cancer cells (MCF-7)info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisBauermann, Liliane de Freitashttp://lattes.cnpq.br/5849925846135968Fachinetto, Roseleihttp://lattes.cnpq.br/7203076675431306Machado, Michel Mansurhttp://lattes.cnpq.br/7651341120825287http://lattes.cnpq.br/3517758264213389Araldi, Isabel Cristina da Costa400300000005600948e5e71-a7c8-46ad-983f-f52ac6f2ac2183a2ca65-e228-4fa1-a59f-305488f5c947d4a64262-0e7e-45c5-910e-0b0aee907c10fad860ca-fefe-46b6-b0ab-6c96a9bef011reponame:Repositório Institucional Manancial UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALDIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdfDIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdfDissertação de Mestradoapplication/pdf1908044http://repositorio.ufsm.br/bitstream/1/18149/1/DIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf8d2d54ff86ded542aeb6a3a4dcb70214MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/18149/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/18149/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53TEXTDIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf.txtDIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf.txtExtracted texttext/plain100536http://repositorio.ufsm.br/bitstream/1/18149/4/DIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf.txtcbc91bd195c0c99bf32a69873f8595f0MD54THUMBNAILDIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf.jpgDIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf.jpgIM Thumbnailimage/jpeg4169http://repositorio.ufsm.br/bitstream/1/18149/5/DIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf.jpgee6395effb6fb4af75bf97ff46920eceMD551/181492019-09-06 03:01:45.86oai:repositorio.ufsm.br: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ório Institucionalhttp://repositorio.ufsm.br/PUBhttp://repositorio.ufsm.br/oai/requestouvidoria@ufsm.bropendoar:39132019-09-06T06:01:45Repositório Institucional Manancial UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas
dc.title.alternative.eng.fl_str_mv Evaluation of resveratrol radiomodifier effect on irradiated breast cancer cells (MCF-7)
title Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas
spellingShingle Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas
Araldi, Isabel Cristina da Costa
Radiação ionizante
Resveratrol
Radioterapia
Neoplasias
Radiossensibilização
Ionizing radiation
Resveratrol
Radiotherapy
Radiosensitization
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas
title_full Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas
title_fullStr Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas
title_full_unstemmed Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas
title_sort Avaliação do efeito radiomodificador do resveratrol sobre células de câncer de mama (MCF-7) irradiadas
author Araldi, Isabel Cristina da Costa
author_facet Araldi, Isabel Cristina da Costa
author_role author
dc.contributor.advisor1.fl_str_mv Bauermann, Liliane de Freitas
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/5849925846135968
dc.contributor.referee1.fl_str_mv Fachinetto, Roselei
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/7203076675431306
dc.contributor.referee2.fl_str_mv Machado, Michel Mansur
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/7651341120825287
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/3517758264213389
dc.contributor.author.fl_str_mv Araldi, Isabel Cristina da Costa
contributor_str_mv Bauermann, Liliane de Freitas
Fachinetto, Roselei
Machado, Michel Mansur
dc.subject.por.fl_str_mv Radiação ionizante
Resveratrol
Radioterapia
Neoplasias
Radiossensibilização
topic Radiação ionizante
Resveratrol
Radioterapia
Neoplasias
Radiossensibilização
Ionizing radiation
Resveratrol
Radiotherapy
Radiosensitization
CNPQ::CIENCIAS DA SAUDE::FARMACIA
dc.subject.eng.fl_str_mv Ionizing radiation
Resveratrol
Radiotherapy
Radiosensitization
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Malignant neoplasias constitute a public health issue, with around 600 thousand new cases of cancer projected to be diagnosed in Brazil between 2016 and 2017. In this context, breast cancer is the most common type in women, reaching around 28% of Brazilian women. Radiation therapy is a therapeutic modality commonly applied in cases of breast cancer in different stages. However, radioresistance, cutaneous radiation syndrome and the occurrence of new neoplasias in healthy cells are the main side effects of this practice. Therefore, the aim of this work was to assess the potential of resveratrol (RV) as a radiosensitizer radiomodifier on breast cancer cells of the lineage MCF-7. For this end, cells were initially treated with different RV doses (0, 10, 30 and 100μM) for 24 hours and then exposed to ionizing radiation (IR) (0, 1, 2 e 3 grays). The results show that the most cytotoxic treatment combination was 10μM and 3 grays, which were the doses chosen for the additional tests. Cellular death assessment through flow cytometry showed that, in 24 hours cell cultures after IR, necrosis/senescence seem to be related to cytotoxicity, besides the activation of extrinsic apoptosis. This phenomenon was clear when the high activity of caspases 3 and 8, and the low bax/bcl-2 ratio were observed. Tests involving oxidative metabolism show that RV and IR are effective together, causing great oxidative damage in DNA, proteins and cellular lipids, as well as diminishing the activity of the antioxidative enzymes dismutase (SOD) and catalase (CAT). The high expression of p53 indicates not to be primarily related to intrinsic apoptosis, but to be indeed related to the interruption of cell cycle in the S phase, which was observed in 72 hours cellular cultures after IR. Thus, the pro-oxidative condition established by the treatment combination, together with the high level of the p53 expression, allow us to suggest that the significant decrease of cellular proliferation in 72 hours cultures seems to be related to the irreversible growth interruption linked to necrosis/senescence, as well as apoptosis activation.
publishDate 2016
dc.date.issued.fl_str_mv 2016-11-28
dc.date.accessioned.fl_str_mv 2019-09-05T18:12:12Z
dc.date.available.fl_str_mv 2019-09-05T18:12:12Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/18149
url http://repositorio.ufsm.br/handle/1/18149
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 400300000005
dc.relation.confidence.fl_str_mv 600
dc.relation.authority.fl_str_mv 948e5e71-a7c8-46ad-983f-f52ac6f2ac21
83a2ca65-e228-4fa1-a59f-305488f5c947
d4a64262-0e7e-45c5-910e-0b0aee907c10
fad860ca-fefe-46b6-b0ab-6c96a9bef011
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Farmacologia
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Farmacologia
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Repositório Institucional Manancial UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Repositório Institucional Manancial UFSM
collection Repositório Institucional Manancial UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/18149/1/DIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf
http://repositorio.ufsm.br/bitstream/1/18149/2/license_rdf
http://repositorio.ufsm.br/bitstream/1/18149/3/license.txt
http://repositorio.ufsm.br/bitstream/1/18149/4/DIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf.txt
http://repositorio.ufsm.br/bitstream/1/18149/5/DIS_PPGFARMACOLOGIA_2016_ARALDI_ISABEL.pdf.jpg
bitstream.checksum.fl_str_mv 8d2d54ff86ded542aeb6a3a4dcb70214
4460e5956bc1d1639be9ae6146a50347
2f0571ecee68693bd5cd3f17c1e075df
cbc91bd195c0c99bf32a69873f8595f0
ee6395effb6fb4af75bf97ff46920ece
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional Manancial UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv ouvidoria@ufsm.br
_version_ 1808854706393448448